Wide Open Agriculture Adds Three Asian Manufacturers to Its Lupin Scale-Up Race

Wide Open Agriculture has signed three new non-binding framework agreements with manufacturers in Vietnam, India, and Indonesia, bringing its total lupin ingredient contract manufacturing partner shortlist to four as it advances a capital-light production strategy.
By Josua Ferreira -
  • WOA has signed framework agreements with VLS (Vietnam), OMN9 (India), and Haldin (Indonesia), bringing total prospective manufacturing partners to four after the Proeon agreement announced on 10 August 2026.
  • The agreements are non-binding on commercial terms but carry enforceable IP protections — manufacturers cannot produce lupin-based products for themselves or third parties during the term and for five years post-termination.
  • VLS carries a conditional exclusivity provision: once it completes commercial production of more than 50 tonnes of lupin protein isolate, WOA has agreed to use VLS exclusively, subject to meeting purchase orders and production targets.
  • Each term sheet targets a definitive agreement within 90 days using best endeavours, though this timeframe is explicitly non-binding and no assurance of execution exists.
  • WOA screened more than 95 potential manufacturers and executed more than 12 NDAs to reach this four-partner shortlist, with additional framework agreements possible as discussions continue.
Summarise with AI:

WOA expands its manufacturing partner network to four across Asia

Wide Open Agriculture (ASX: WOA) has signed three additional non-binding framework agreements for contract manufacturing of its proprietary lupin-based ingredients, bringing the total number of prospective partners to four. The three new signatories are Vietnam LifeScience Company Limited (VLS) in Vietnam, Shree Ram Agro Products operating as OMN9 (OMN9) in India, and PT Haldin Pacific Semesta (Haldin) in Indonesia.

The agreements build directly on the framework agreement announced on 10 August 2026, extending an established process rather than representing a standalone event. Together they advance WOA’s strategy of shifting to a lower-cost, capital-light contract manufacturing model.

The Proeon framework agreement, signed on 10 August 2026 with a Netherlands and India-based plant protein manufacturer, established the first framework in this partner selection process and set the structural template that the three subsequent agreements now follow.

To reach this shortlist, WOA has identified more than 95 potential manufacturers, signed more than 12 non-disclosure agreements, and progressed a small number of candidates to framework agreement stage — now totalling four prospective partners.

WOA Partner Selection Funnel

Understanding WOA’s structured partner selection process

A framework agreement is a protected pathway for technical and commercial assessment. It is not a commercial commitment and does not represent a revenue event.

The key distinction lies in what is binding and what is not. The intellectual property, restraint, and confidentiality provisions, as well as costs, governing law, and dispute resolution, are binding and enforceable. All other terms — including price, delivery, and commercial structure — are non-binding, and neither party has a claim against the other if a definitive commercial agreement is not ultimately executed.

Running multiple candidates in parallel allows WOA to compare technical capability and commercial terms without locking in prematurely, while keeping its intellectual property fully protected throughout the process. Each term sheet contemplates that the parties will use best endeavours to negotiate a definitive agreement within 90 days, though this timeframe is explicitly non-binding.

Each framework agreement covers:

  • IP protection (binding and enforceable, continuing for five years post-termination)
  • Technical information sharing on process steps, equipment, and production parameters, and a pathway to trial production — included in the VLS and Haldin term sheets; OMN9’s term sheet does not address these provisions, with information sharing governed by the confidentiality provisions and to be dealt with in the definitive agreement

Manufacturers may not produce lupin-based products for themselves or any third party during the term of any agreement, and for five years after its termination. WOA retains full ownership of all intellectual property relating to lupin products, including any improvements or developments made during the relationship.

What sets each partner apart

VLS operates a dedicated pea protein manufacturing facility in the Bau Xeo Industrial Park in Dong Nai Province, Vietnam, drawing on more than 30 years of pea protein expertise within its team. VLS manufactures premium plant protein for supplement, nutrition, and food brands internationally, and its protein isolate manufacturing capability and export orientation are directly relevant to WOA’s lupin platform.

VLS carries a notable conditional exclusivity provision: once VLS completes commercial production of more than 50 tonnes of lupin protein isolate, WOA has agreed to use VLS exclusively for its lupin manufacturing requirements for a period ending five years from the date of the agreement, provided VLS continues to accept WOA’s firm purchase orders and meets production targets in line with WOA’s rolling forecasts. The parties have also agreed to explore potential joint venture opportunities to manufacture large-scale commercial quantities of lupin protein, lupin fibre, and lupin oil.

The lupin fibre co-product recovered alongside protein isolate during processing has received independent CSIRO validation for heat stability, shear resistance, and water-binding capacity, positioning it as a second high-value ingredient stream within the same manufacturing agreements now being negotiated.

OMN9 is an Indian plant protein producer specialising in mung bean protein isolate and mung bean starch, with operations in Jodhpur, Rajasthan and in Delhi. OMN9 supplies clean-label plant protein ingredients to food, beverage, and nutraceutical customers, and brings established protein isolate manufacturing capability relevant to WOA’s lupin-based ingredients. The parties will also discuss potential joint venture opportunities to manufacture large-scale commercial quantities of lupin protein and co-products in India.

Haldin is an Indonesian natural ingredients manufacturer based in Cibitung, Bekasi, West Java, operating multiple production facilities including liquid and powder extraction plants, a coconut processing facility, and a materials preparation centre. Haldin supplies natural extracts, spray-dried powders, and functional ingredients to food, beverage, nutraceutical, and cosmetic customers internationally. Under this agreement, WOA is not bound to use Haldin exclusively for its manufacturing requirements, and no minimum volume or value of orders applies.

Partner Country Specialisation Exclusivity JV Exploration
VLS Vietnam Plant protein (pea protein isolate); export-oriented nutrition and food manufacturing Conditional: WOA to use VLS exclusively once VLS completes commercial production of more than 50 tonnes of lupin protein isolate, subject to meeting purchase orders and production targets Yes — lupin protein, lupin fibre, and lupin oil
OMN9 India Plant protein isolate (mung bean protein and starch); clean-label food, beverage, and nutraceutical supply OMN9 may not manufacture lupin-based products for itself or any third party during the term and for five years post-termination; no reciprocal exclusivity obligation on WOA stated Yes — lupin protein and co-products in India
Haldin Indonesia Natural ingredients; liquid and powder extraction; functional ingredients for food, beverage, nutraceutical, and cosmetic sectors Haldin may not manufacture lupin-containing products for itself or any third party; WOA is not bound to use Haldin exclusively and no minimum volume or value of orders applies Not stated

Craig Swan, Chief Executive Officer

“Signing three further framework agreements shows our partner selection process is progressing. With intellectual property protections now in place with highly respected manufacturers across three countries, we can complete technical and commercial feasibility work in parallel… In the future we intend to progress to the stage of a definitive agreement with the partner best suited to scale our lupin ingredients.”

Next steps and what investors should watch

With IP protections now in place, each party can begin sharing detailed technical information on process steps, equipment, and production parameters, building toward trial production. Next steps include developing proposed timelines for ramp-up activities and working toward alignment on key commercial terms.

Each term sheet contemplates the parties using best endeavours to negotiate a definitive agreement within 90 days, though this timeframe is explicitly non-binding and there is no assurance that a definitive agreement will be reached with any party. WOA has also disclosed that additional framework agreements may follow as it continues active discussions with other prospective partners.

Near-term milestones investors should monitor:

  1. Technical feasibility assessments commencing across all four partners
  2. Commercial terms alignment and proposed ramp-up timelines
  3. Definitive agreement reached with a preferred partner (no guaranteed timeline)
  4. Further framework agreements possible, per company disclosure

Don’t Miss the Next Consumer Sector Breakout

Big News Blast delivers FREE breaking ASX news to your inbox within minutes of release, complete with in-depth analysis already done for you. Join 20,000+ subscribers who stay ahead of the market the moment announcements hit. Click the “Free Alerts” button at Big News Blast to start receiving alerts today.


Frequently Asked Questions

What are the Wide Open Agriculture contract manufacturing agreements and what do they mean for investors?

Wide Open Agriculture has signed non-binding framework agreements with four prospective manufacturers — Proeon, VLS (Vietnam), OMN9 (India), and Haldin (Indonesia) — to assess the technical and commercial feasibility of producing its lupin-based ingredients. These agreements protect WOA's intellectual property but do not represent commercial commitments or revenue events.

What is a framework agreement in the context of WOA's manufacturing strategy?

A framework agreement is a protected pathway for technical and commercial assessment — it makes IP protection, confidentiality, and restraint provisions legally binding, but leaves commercial terms like price and delivery non-binding. Neither party is obligated to proceed to a definitive agreement.

What is the 90-day timeline in WOA's framework agreements?

Each framework agreement contemplates the parties using best endeavours to negotiate a definitive commercial agreement within 90 days, but this timeframe is explicitly non-binding and WOA has disclosed there is no assurance a definitive agreement will be reached with any partner.

What is the VLS exclusivity provision in Wide Open Agriculture's Vietnam agreement?

Once VLS completes commercial production of more than 50 tonnes of lupin protein isolate, WOA has agreed to use VLS exclusively for its lupin manufacturing requirements for five years, provided VLS continues to accept WOA's firm purchase orders and meets production targets in line with WOA's rolling forecasts.

How many manufacturers did Wide Open Agriculture screen before reaching four framework agreements?

WOA identified more than 95 potential manufacturers, signed more than 12 non-disclosure agreements, and progressed a small number of candidates to framework agreement stage, resulting in four prospective partners across Vietnam, India, Indonesia, and the Netherlands and India-based Proeon.

Josua Ferreira
By Josua Ferreira
Partnership Director
Josua Ferreira holds a Bachelor of Commerce in Marketing and Advertising and brings a background in publication, business development, and ASX market storytelling. He has worked with listed companies across the resource sector and broader market, combining sharp commercial instincts with a genuine commitment to keeping investors informed.
Learn More

Breaking ASX Alerts Direct to Your Inbox

Join +20,000 subscribers receiving alerts.

Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.

About the Publisher

Sponsored